// company-profile

Kyverna Therapeutics, Inc. Insider Trading

KYTX

Every SEC Form 4 insider trading filing for Kyverna Therapeutics, Inc. (KYTX) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings41Insiders34
// api This Kyverna Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=KYTX" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Kyverna Therapeutics, Inc. insiders bought $0 (9 transactions) and sold $36K (1 transaction).

  • Most active insider: Cohen Fred E with 2 transactions totaling $0.
  • Largest single sale: $36K by Shaw Christi on May 27, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Kyverna Therapeutics, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$110.1M
QoQ change
-61.5%
Reporting period
2026-06-30
#1
GILEAD SCIENCES, INC.
CIK 882095
$36.8M
4.1M shares
#2
AIGH Capital Management LLC
CIK 1835943
$18.5M
2.1M shares
#3
BlackRock, Inc.
CIK 2012383
$16.7M
1.9M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
May 27, 2026Cohen Fred EKYTX
Award
5,093$0.00$0K
May 27, 2026Aktar MertKYTX
Award
5,093$0.00$0K
May 27, 2026Aktar MertKYTX
Award
20,582$0.00$0K
May 27, 2026Shaw ChristiKYTX
Tax Withholding
4,194$8.59$36K
May 27, 2026SEIDENBERG BETH CKYTX
Award
20,582$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →